Daniel V.T. Catenacci
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Gastrointestinal Tumor Research and Treatment 32
- Oncology 102
- Pancreatic and Hepatic Oncology Research 33
- Colorectal Cancer Treatments and Studies 31
- Cancer Immunotherapy and Biomarkers 30
- Co-authors
- Hyun Cheol ChungYung‐Jue BangKei MuroJeffrey S. RossSiraj M. AliTalia GolanDo‐Youn OhAdrian Murphy
- Journals
- Journal of Clinical Oncology (56 papers)Annals of Oncology (28 papers)The Oncologist (8 papers)Clinical Cancer Research (6 papers)Cancer Research (5 papers)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Daniel V.T. Catenacci
161 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 4.1k
- Gastroenterology 634
- Pulmonary and Respiratory Medicine 2.9k
- Cancer Research 1.2k
- Surgery 2.8k
Countries citing papers authored by Daniel V.T. Catenacci
This map shows the geographic impact of Daniel V.T. Catenacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel V.T. Catenacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel V.T. Catenacci more than expected).
Fields of papers citing papers by Daniel V.T. Catenacci
This network shows the impact of papers produced by Daniel V.T. Catenacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel V.T. Catenacci. The network helps show where Daniel V.T. Catenacci may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel V.T. Catenacci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2022 | 36 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 63 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 117 | |
| 9 | 2020 | 3 | |
| 10 | 2020 | 81 | |
| 11 | 2019 | 147 | |
| 12 | 2019 | 67 | |
| 13 | 2019 | 56 | |
| 14 | Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer Hit paper breakdown → | 2019 | 441 |
| 15 | 2018 | 79 | |
| 16 | 2018 | 42 | |
| 17 | 2017 | 14 | |
| 18 | 2017 | 26 | |
| 19 | Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial Hit paper breakdown → | 2016 | 848 |
| 20 | 2014 | 56 |
About Daniel V.T. Catenacci
Daniel V.T. Catenacci is a scholar working on Gastroenterology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Hepatology, having authored 167 papers that have together received 6.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (71 papers), Cancer Genomics and Diagnostics (34 papers), Pancreatic and Hepatic Oncology Research (33 papers), Gastrointestinal Tumor Research and Treatment (32 papers), Colorectal Cancer Treatments and Studies (31 papers), Cancer Immunotherapy and Biomarkers (30 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers) and Esophageal Cancer Research and Treatment (19 papers). The work is most often cited by research in Oncology (4.1k citations), Gastroenterology (634 citations), Pulmonary and Respiratory Medicine (2.9k citations), Cancer Research (1.2k citations) and Surgery (2.8k citations). Daniel V.T. Catenacci has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Hyun Cheol Chung, Yung‐Jue Bang, Kei Muro, Jeffrey S. Ross, Siraj M. Ali, Talia Golan, Do‐Youn Oh, Adrian Murphy, Mitesh J. Borad and Eric Van Cutsem. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.